Amgen (AMGN) Revenue — Quarter Ended Dec 31, 2024
Revenue increased in the reporting quarter. The growth was evident both sequentially and compared to the same period last year.
Key takeaway
Quarter ended Dec 31, 2024 · FY2024 Q4
Revenue increased in the reporting quarter. The growth was evident both sequentially and compared to the same period last year.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$9.1B
Revenue reported for this quarter.
Quarter-over-quarter
+6.9%
Change from the immediately preceding quarter.
Year-over-year
+10.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$33.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2024 | $7.4B | +22.0% |
| Jun 30, 2024 | $8.4B | +20.1% |
| Sep 30, 2024 | $8.5B | +23.2% |
| Dec 31, 2024 | $9.1B | +10.9% |
Revenue performance
The company posted higher revenue for the quarter, continuing an upward trajectory seen in recent periods.
Quarterly comparison
Compared to the immediately preceding quarter, revenue rose. Compared to the same quarter one year earlier, revenue also increased.
What to watch
The consistent revenue growth across recent quarters may be a point of interest in future assessments.